Pregnant with metastatic neuroendocrine tumour of the ovary: what now?

by Pistilli, B, Grana, CM, Fazio, N, Cavaliere, A, Ferrari, ME, Bodei, L, Baio, SM, Scambia, G, Paganelli, G, Peccatori, FA
Published 2012

“Short Course” of Nonpegylated Liposomal Doxorubicin Plus Paclitaxel and Trastuzumb as Primary Systemic Therapy for Operable and Locally-Advanced Breast Cancer: A Phase II Study (P...

by Rossi, D., Pistilli, B., Morale, D., Baldelli, Casadei, V., Benedetti, G., Alessandroni, P., Catalano, V., Giordani, P., Graziano, F., Fedeli, S. Luzi, Fiorentini, G.
Published in World J Oncol (2011)

Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy

by Pistilli, B., Pluard, T., Urruticoechea, A., Farci, D., Kong, A., Bachelot, T., Chan, S., Han, H. S., Jerusalem, G., Urban, P., Robinson, D., Mouhaër, S. L., Tomaso, E. D., Massacesi, C., Saura, C.
Published in Breast Cancer Res Treat (2017)

1710P International multicentric evaluation of breast cancer patients’ satisfaction and experience with oncology telemedicine visits (TV) during the COVID-19 outbreak

by Bizot, A., Heudel, P-E., Karimi, M., Levy, C., Vanlemmens, L., Uzan, C., Deluche, E., Genet, D., Saghatchian, M., Giacchetti, S., Grenier, J., Patsouris, A., Dieras, V.C., Pierga, J-Y., Petit, T., Ladoire, S., Jacot, W., Delaloge, S., Lambertini, M., Pistilli, B.
Published in Ann Oncol (2020)

Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME)

by Dano, D., Lardy-Cleaud, A., Monneur, A., Quenel-Tueux, N., Levy, C., Mouret-Reynier, M.-A., Coudert, B., Mailliez, A., Ferrero, J.-M., Guiu, S., Campone, M., de La Motte Rouge, T., Petit, T., Pistilli, B., Dalenc, F., Simon, G., Lerebours, F., Chabaud, S., Bertucci, F., Gonçalves, A.
Published in ESMO Open (2021)